Inge van der Putten nominated for the NVTAG prize 2018
Proud that our VHC colleague Inge van der Putten has been chosen as one of the 3 selected nominees to win the HTA prize 2018 of the Dutch Society for Technology Assessment in Health Care (NVTAG) for her article “Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands” in Health Policy which gains insight into which information plays a role in introduction of HPV vaccination program in the Netherlands by conducting a document analysis.
Also read
-
Is the risk of cancer the same for everyone?
Valery Lemmens (GROW) conducts research on cancer, prevention, and how society is designed for making unhealthy choices.
-
Most prestigious European grant to two UM scientists
Two Maastricht University professors are to receive the most prestigious European research grant for individual researchers: an ERC Advanced Grant, worth over €2.5 million. They are Lorenzo Moroni (MERLN) and Alexander Sack (FPN).
-
A new outlook on rehabilitation care
Ivan Huijnen (CAPHRI) aims to shift from the biomedical 'disorder-focused' thinking to an integral view on healthcare.
